Burning Rock Biotech Limited (BNR)

NASDAQ: BNR · IEX Real-Time Price · USD
3.01
-0.02 (-0.66%)
At close: Feb 7, 2023, 4:00 PM
3.02
+0.01 (0.33%)
After-hours: Feb 7, 2023, 6:42 PM EST
-0.66%
Market Cap 318.23M
Revenue (ttm) 78.94M
Net Income (ttm) -139.74M
Shares Out 105.73M
EPS (ttm) -1.34
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 127,219
Open 3.04
Previous Close 3.03
Day's Range 2.88 - 3.04
52-Week Range 1.70 - 11.27
Beta 0.07
Analysts Buy
Price Target 6.95 (+130.9%)
Earnings Date Mar 20, 2023

About BNR

Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and prognosis prediction tests applicable to a range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian canc... [Read more]

Sector Healthcare
IPO Date Jun 12, 2020
Employees 1,394
Stock Exchange NASDAQ
Ticker Symbol BNR
Full Company Profile

Financial Performance

In 2021, BNR's revenue was 507.86 million, an increase of 18.13% compared to the previous year's 429.90 million. Losses were -796.70 million, 68.8% more than in 2020.

Financial numbers in CNY Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for BNR stock is "Buy." The 12-month stock price forecast is $6.95, which is an increase of 130.90% from the latest price.

Price Target
$6.95
(130.90% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Burning Rock provides an update on 2022 revenue guidance

GUANGZHOU, China, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation se...

3 weeks ago - GlobeNewsWire

Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test

IRVINE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Burning Rock (NASDAQ/LSE: BNR), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology...

1 month ago - GlobeNewsWire

Burning Rock Biotech Limited Sponsored ADR (BNR) Upgraded to Buy: What Does It Mean for the Stock?

Burning Rock Biotech Limited Sponsored ADR (BNR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in th...

2 months ago - Zacks Investment Research

Burning Rock Reports Third Quarter 2022 Financial Results

GUANGZHOU, China, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation se...

3 months ago - GlobeNewsWire

Admission to Trading on the London Stock Exchange

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WO...

3 months ago - GlobeNewsWire

Burning Rock Announces Publication of Prospectus in connection with Direct Listing on the London Stock Exchange

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WO...

3 months ago - GlobeNewsWire

Burning Rock Provides Third Quarter 2022 Business Updates and Schedules Earnings Release on November 16, 2022

GUANGZHOU, China, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS...

3 months ago - GlobeNewsWire

Burning Rock Announces Publication of Registration Document and Potential Direct Listing on the London Stock Exchange

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WO...

3 months ago - GlobeNewsWire

Burning Rock Announces Results of 2022 Annual General Meeting

GUANGZHOU, China, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (N...

5 months ago - GlobeNewsWire

Burning Rock Biotech Limited Sponsored ADR (BNR) Reports Q2 Loss, Tops Revenue Estimates

Burning Rock Biotech Limited Sponsored ADR (BNR) delivered earnings and revenue surprises of -2.78% and 0.69%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahe...

5 months ago - Zacks Investment Research

Burning Rock Reports Second Quarter 2022 Financial Results

GUANGZHOU, China, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS...

5 months ago - GlobeNewsWire

Burning Rock Provides Second Quarter 2022 Business Updates and Schedules Earnings Release on August 31, 2022

GUANGZHOU, China, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS...

6 months ago - GlobeNewsWire

Burning Rock Announces 2022 Annual General Meeting to be Held on September 8, 2022

GUANGZHOU, China, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (NG...

6 months ago - GlobeNewsWire

Burning Rock Announces Resignation of Director

GUANGZHOU, China, July 14, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS...

7 months ago - GlobeNewsWire

Burning Rock Announces the Launch of China's First Prospective Interventional Validation Study on Multi-Cancer Early Detection - the PREVENT Study

CHENGDU, China, June 30, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) ...

7 months ago - GlobeNewsWire

Burning Rock Announces Changes to Board Composition

GUANGZHOU, China, June 24, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS...

8 months ago - GlobeNewsWire

Burning Rock Announces US$10 Million Share Repurchase Program

GUANGZHOU, China, June 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS...

8 months ago - GlobeNewsWire

Burning Rock Announces Plan to Pursue An Alternative Listing

GUANGZHOU, China, June 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS...

8 months ago - GlobeNewsWire

Burning Rock Presents Latest Clinical Data from THUNDER Study at 2022 ASCO Annual Meeting

SHANGHAI , June 15, 2022 /PRNewswire/ -- Burning Rock (NASDAQ:BNR) presented the final results from the multi-center case-control THUNDER study (THe UNintrusive Detection of EaRly-stage cancer, NCT048...

8 months ago - PRNewsWire

Cathie Wood Is Selling Gene Editing Stocks. Here's Why.

Cathie Wood has recently sold off large positions in several gene-editing stocks from her ARKG ETF. What's behind Wood's latest moves?

Other symbols: ARKGEDITIONS
8 months ago - InvestorPlace

Burning Rock Receives CE Mark for its OverC™ Multi-Cancer Detection Blood Test Kit

SHANGHAI , June 1, 2022 /PRNewswire/ -- Burning Rock Biotech Limited (NASDAQ: BNR, the "Company" or "Burning Rock") announced that it has received CE marking for its OverC™ Multi-Cancer Detection Bloo...

8 months ago - PRNewsWire

Burning Rock Reports First Quarter 2022 Financial Results

GUANGZHOU, China, May 31, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS)...

9 months ago - GlobeNewsWire

Burning Rock Schedules First Quarter of 2022 Earnings Release on May 31, 2022

GUANGZHOU, China, May 16, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS)...

9 months ago - GlobeNewsWire

Tesla Bull Cathie Wood Bought $1M Shares In This Biotech Stock Today

Tesla Inc (NASDAQ: TSLA) bull Cathie Wood led Ark Investment Management on Thursday further raised its exposure in China-based biotech company Burning Rock Biotech Ltd (NASDAQ: BNR). The investment fi...

11 months ago - Benzinga

Burning Rock Reports Fourth Quarter and Full Year 2021 Financial Results

GUANGZHOU, China, March 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NG...

11 months ago - GlobeNewsWire